Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04585646 · ClinicalTrials.gov registry record · NA
A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT04585646 is a NA study that has completed, run by CooperVision. The registered enrollment target is 64 participants.
The verdict
NCT04585646, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.
Interventions
- DEVICE Orion daily disposable contact lens
- DEVICE Gemini daily disposable contact lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04585646
The ClinicalTrials.gov registry entry for NCT04585646 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Orion daily disposable contact lens is the first listed.
NCT04585646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04585646 about?
NCT04585646 is a clinical study titled "A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens". The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.
What is the current status of trial NCT04585646?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2020-09-14. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04585646?
The interventions under investigation include: Orion daily disposable contact lens (DEVICE), Gemini daily disposable contact lens (DEVICE).
Who is sponsoring clinical trial NCT04585646?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.